Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease : Does aspirin make a difference?
Aspirin (ASA) often is used to prevent thrombosis in infants with congenital heart disease after placement of a systemic-to-pulmonary artery shunt, but its effect on outcomes is unknown. The present multicenter study prospectively collected data on 1-year postoperative rates of death, shunt thrombos...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2007-07, Vol.116 (3), p.293-297 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aspirin (ASA) often is used to prevent thrombosis in infants with congenital heart disease after placement of a systemic-to-pulmonary artery shunt, but its effect on outcomes is unknown.
The present multicenter study prospectively collected data on 1-year postoperative rates of death, shunt thrombosis, or hospitalization age |
---|---|
ISSN: | 0009-7322 1524-4539 |
DOI: | 10.1161/CIRCULATIONAHA.106.652172 |